Study of the Association of Polymorphisms of p53 and p21 with the Risk of Development of Stomach Cancer
- Authors: Dmitrieva A.I.1,2, Serebryakova V.A.1,2, Rakitin S.S.1, Kudyakov L.A.2, Novitskii V.V.1,3, Yankovich K.I.1,2, Sevostyanova N.V.1,3
- 
							Affiliations: 
							- Siberian State Medical University, Ministry of Health of the Russian Federation
- Tomsk Regional Oncology Center
- National Research Tomsk State University
 
- Issue: Vol 164, No 1 (2017)
- Pages: 95-98
- Section: Oncology
- URL: https://journals.rcsi.science/0007-4888/article/view/239390
- DOI: https://doi.org/10.1007/s10517-017-3932-6
- ID: 239390
Cite item
Abstract
A real-time PCR with hybridization and fluorescent detection was used to analyze the distribution of p53 G215C, p21A1026G, and G369C gene polymorphisms in patients with stomach cancer and healthy subjects. It was found that allele C, genotypes of CC and GC of G215C p53, and G369C p21 polymorphisms and allele A and AA and GA genotypes of A1026G p21 polymorphism are significantly associated with the risk of stomach cancer development.
About the authors
A. I. Dmitrieva
Siberian State Medical University, Ministry of Health of the Russian Federation; Tomsk Regional Oncology Center
							Author for correspondence.
							Email: alladmitrieva@mail.ru
				                					                																			                												                	Russian Federation, 							Moscow; Tomsk						
V. A. Serebryakova
Siberian State Medical University, Ministry of Health of the Russian Federation; Tomsk Regional Oncology Center
														Email: alladmitrieva@mail.ru
				                					                																			                												                	Russian Federation, 							Moscow; Tomsk						
S. S. Rakitin
Siberian State Medical University, Ministry of Health of the Russian Federation
														Email: alladmitrieva@mail.ru
				                					                																			                												                	Russian Federation, 							Moscow						
L. A. Kudyakov
Tomsk Regional Oncology Center
														Email: alladmitrieva@mail.ru
				                					                																			                												                	Russian Federation, 							Tomsk						
V. V. Novitskii
Siberian State Medical University, Ministry of Health of the Russian Federation; National Research Tomsk State University
														Email: alladmitrieva@mail.ru
				                					                																			                												                	Russian Federation, 							Moscow; Tomsk						
K. I. Yankovich
Siberian State Medical University, Ministry of Health of the Russian Federation; Tomsk Regional Oncology Center
														Email: alladmitrieva@mail.ru
				                					                																			                												                	Russian Federation, 							Moscow; Tomsk						
N. V. Sevostyanova
Siberian State Medical University, Ministry of Health of the Russian Federation; National Research Tomsk State University
														Email: alladmitrieva@mail.ru
				                					                																			                												                	Russian Federation, 							Moscow; Tomsk						
Supplementary files
 
				
			 
					 
						 
						 
						 
						 
				 
  
  
  
  
  Email this article
			Email this article  Open Access
		                                Open Access Access granted
						Access granted Subscription Access
		                                		                                        Subscription Access
		                                					